Inoue, K.; Omura, M.; Sugisawa, C.; Tsurutani, Y.; Saito, J.; Nishikawa, T.
Clinical Utility of the Adrenocorticotropin Stimulation Test with/without Dexamethasone Suppression for Definitive and Subtype Diagnosis of Primary Aldosteronism. Int. J. Mol. Sci. 2017, 18, 948.
https://doi.org/10.3390/ijms18050948
AMA Style
Inoue K, Omura M, Sugisawa C, Tsurutani Y, Saito J, Nishikawa T.
Clinical Utility of the Adrenocorticotropin Stimulation Test with/without Dexamethasone Suppression for Definitive and Subtype Diagnosis of Primary Aldosteronism. International Journal of Molecular Sciences. 2017; 18(5):948.
https://doi.org/10.3390/ijms18050948
Chicago/Turabian Style
Inoue, Kosuke, Masao Omura, Chiho Sugisawa, Yuya Tsurutani, Jun Saito, and Tetsuo Nishikawa.
2017. "Clinical Utility of the Adrenocorticotropin Stimulation Test with/without Dexamethasone Suppression for Definitive and Subtype Diagnosis of Primary Aldosteronism" International Journal of Molecular Sciences 18, no. 5: 948.
https://doi.org/10.3390/ijms18050948
APA Style
Inoue, K., Omura, M., Sugisawa, C., Tsurutani, Y., Saito, J., & Nishikawa, T.
(2017). Clinical Utility of the Adrenocorticotropin Stimulation Test with/without Dexamethasone Suppression for Definitive and Subtype Diagnosis of Primary Aldosteronism. International Journal of Molecular Sciences, 18(5), 948.
https://doi.org/10.3390/ijms18050948